Biomarkers · Cardiac & Hemodynamics
Copeptin
Lower values carry lower risk. Not measured in our NHANES panel; the curve is synthesised from the published association.
Hazard ratio relative to the curve's reference value, as synthesised from the published association.
Published hazard ratio1.70top vs bottom quarter (95% CI 1.20–2.50) · Community-dwelling patients presenting to general practitioners (e.g., for respiratory infection), 10-year prospective follow-up, mortality 9.8%
Where people sit
Population percentiles (pmol/L) by sex and age band. Cycle or source as recorded in the catalogue.
| Sex | Age | 5th | 25th | Median | 75th | 95th | n | Cycle / source |
|---|---|---|---|---|---|---|---|---|
| All | 20-39 | 1.29 | 2.58 | 3.86 | 5.43 | 8.74 | 359 | Morgenthaler NG, Struc… |
| All | 40-59 | 1.40 | 2.80 | 4.20 | 5.90 | 9.50 | 359 | Morgenthaler NG, Struc… |
| All | 60+ | 1.53 | 3.05 | 4.58 | 6.43 | 10.4 | 359 | Morgenthaler NG, Struc… |
| All | all | 1.40 | 2.80 | 4.20 | 5.90 | 9.50 | 359 | Morgenthaler NG, Struc… |
| Men | all | 2.13 | 3.40 | 4.70 | 6.50 | 10.4 | 359 | Morgenthaler NG, Struc… |
| Women | all | 1.60 | 2.58 | 3.60 | 5.02 | 8.11 | 359 | Morgenthaler NG, Struc… |
Sources
- Hazard curve: Synthesized from mortality_association (HR=1.7 quartile_extreme); per-SD log(HR)=0.414. Reported as quartile_extreme HR=1.7 for all-cause mortality. Age-adjusted HR for admission copeptin and 10-year all-cause mortality (AUC 0.68). A sepa
- Enhorning S, et al. Copeptin predicts 10-year all-cause mortality in community patients: a 10-year prospective cohort study. Clinical Chemistry and Laboratory Medicine. 2016;54(10):1681-1690.